Home | Welcome to Contract Pharma   
Last Updated Saturday, April 19 2014
Print

Topics - Preclinical Outsourcing


Refine by Date:
From: To:
By Gil Roth
Published November 13, 2013
Discovery Labs, Fibrogen, Pluristem, RXi, Tekmira, Vivus, Zysis Read More »
By Gil Roth
Published November 13, 2013
Strong benefits in non-human primate studies Read More »
The Wild West of Basic Discovery
By Nancy Gillett, Charles River Laboratories
Published November 13, 2013
R&D outsourcing issues Read More »
By Kristin Brooks
Published November 6, 2013
Q&A with Ubavka DeNoble, M.D. about small and mid-size company needs Read More »
By Gil Roth
Published November 5, 2013
Triggers $15 mil. payment from Bayer Read More »
By Gil Roth
Published November 5, 2013
OMS721 cuts blood vessel development in half Read More »
By Gil Roth
Published November 1, 2013
Regen BioPharma signs clinical supply contract Read More »
Newsmakers: Biomarkers
By Gil Y. Roth, Contract Pharma
Published October 9, 2013
Vellalore Kakkanaiah of PPD on biomarker development Read More »
By Gil Roth
Published September 30, 2013
Phase I/II trial in type 2 reaches primary endpoints Read More »
By Gil Roth
Published September 26, 2013
Dompe, Exelixis, Lilly, Lumena, NovaRx, ProMetic, Sarepta, Read More »
By Gil Roth
Published September 26, 2013
PBI-4050 passes fox testing, safe to advance Read More »
By Gil Roth
Published September 17, 2013
Smith, Rayner named to help development Read More »
By Gil Roth
Published September 12, 2013
Pact covers nonclinical through registration Read More »
By Gil Roth
Published September 12, 2013
Italian research production facility to cover continent, UK Read More »
By Gil Roth
Published August 26, 2013
CEO David Spaight explains geographic, capacity play Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On